Keith Michael Gottesdiener, CEO & President at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 662 shares at $30.00 ($20K) on 2019-01-16, disclosed to the SEC on 2019-01-17.
Scheduled sale ($20k) by CEO & President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RYTM | SELL | 2019-02-28 | $128K | — | Filing → |
| RYTM | SELL | 2019-02-20 | $748K | — | Filing → |
| RYTM | SELL | 2019-02-15 | $118K | — | Filing → |